Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series

被引:0
|
作者
Guerrieri, Simone [1 ]
Rubin, Martina [1 ,2 ,3 ]
Gattuso, Irene [1 ,3 ]
Zanetta, Chiara [1 ]
Genchi, Angela [1 ,3 ]
Preziosa, Paolo [1 ,2 ,3 ]
Rocca, Maria Assunta [1 ,2 ,3 ]
Filippi, Massimo [1 ,2 ,3 ,4 ,5 ]
Moiola, Lucia [1 ]
机构
[1] IRCCS San Raffaele Sci Inst, Multiple Sclerosis Ctr, Neurol Unit, Via Olgettina 60, I-20132 Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit, Milan, Italy
[3] Univ Vita Salute San Raffaele, Milan, Italy
[4] IRCCS San Raffaele Sci Inst, Neurorehabil Unit, Milan, Italy
[5] IRCCS San Raffaele Sci Inst, Neurophysiol Serv, Milan, Italy
关键词
FINGOLIMOD;
D O I
10.1007/s00415-024-12342-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:3678 / 3681
页数:4
相关论文
共 50 条
  • [1] Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
    Chaudhry, Burhan Z.
    Cohen, Jeffrey A.
    Conway, Devon S.
    NEUROTHERAPEUTICS, 2017, 14 (04) : 859 - 873
  • [2] Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
    Burhan Z. Chaudhry
    Jeffrey A. Cohen
    Devon S. Conway
    Neurotherapeutics, 2017, 14 : 859 - 873
  • [3] Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis
    Roy, Reshmi
    Alotaibi, Alaa A.
    Freedman, Mark S.
    CNS DRUGS, 2021, 35 (04) : 385 - 402
  • [4] Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis
    Reshmi Roy
    Alaa A. Alotaibi
    Mark S. Freedman
    CNS Drugs, 2021, 35 : 385 - 402
  • [5] Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis
    Adnan M. Subei
    Jeffrey A. Cohen
    CNS Drugs, 2015, 29 : 565 - 575
  • [6] Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis
    Subei, Adnan M.
    Cohen, Jeffrey A.
    CNS DRUGS, 2015, 29 (07) : 565 - 575
  • [7] Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: A practical review
    Coyle, Patricia K.
    Freedman, Mark S.
    Cohen, Bruce A.
    Cree, Bruce A. C.
    Markowitz, Clyde E.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (04): : 842 - 855
  • [8] An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
    Dumitrescu, Laura
    Papathanasiou, Athanasios
    Coclitu, Catalina
    Garjani, Afagh
    Evangelou, Nikos
    Constantinescu, Cris S.
    Popescu, Bogdan Ovidiu
    Tanasescu, Radu
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (04) : 495 - 509
  • [9] Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions
    McGinley, Marisa P.
    Cohen, Jeffrey A.
    LANCET, 2021, 398 (10306): : 1184 - 1194
  • [10] Sphingosine-1 Phosphate Receptor Modulators in the Treatment of Multiple Sclerosis
    Shipley, Scott
    Bryant, Casey
    Darais, Dallin
    US PHARMACIST, 2021, 46 (01) : HS1 - HS5